During the past decade, Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" are "Diabetic Macular Edema" (2 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" in a lesser frequency.

Most popular intervention types in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Lampalizumab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials) and "Sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".